Abstract
Targeting the fusogenic machinery of HIV with unnatural ligand libraries.
MeSH terms
-
AIDS Vaccines / immunology
-
AIDS Vaccines / therapeutic use
-
Amino Acid Sequence
-
Anti-HIV Agents / chemical synthesis
-
Anti-HIV Agents / metabolism*
-
Anti-HIV Agents / pharmacology*
-
Anti-HIV Agents / therapeutic use
-
Combinatorial Chemistry Techniques
-
Drug Design
-
HIV Envelope Protein gp41 / chemistry
-
HIV Envelope Protein gp41 / immunology
-
HIV Envelope Protein gp41 / metabolism*
-
HIV Infections / drug therapy
-
HIV Infections / immunology
-
HIV Infections / prevention & control
-
HIV Infections / therapy
-
HIV-1 / drug effects*
-
HIV-1 / immunology
-
HIV-1 / metabolism
-
Humans
-
Ligands
-
Membrane Fusion / drug effects*
-
Membrane Fusion / immunology
-
Peptide Fragments / chemistry
-
Peptide Fragments / immunology
-
Peptide Fragments / metabolism
-
Peptide Library*
Substances
-
AIDS Vaccines
-
Anti-HIV Agents
-
HIV Envelope Protein gp41
-
Ligands
-
Peptide Fragments
-
Peptide Library